Kraig Biocraft Laboratories In Stock Price, News & Analysis

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) released a video showcasing its advanced silkworm breeding facility in Vietnam. This facility is dedicated to producing eco-friendly spider silk and is expected to meet production demands through 2025.

The video marks the beginning of a series aimed at providing insights into the Company's recombinant spider silk production operations. Kraig Labs believes this facility is one of the most advanced in the world, enhancing their capacity for cost-effective production. Future videos will explore R&D labs and breeding operations.

Kraig Biocraft Laboratories, Inc. (KBLB) has signed its first third-party production contract for large-scale manufacturing of recombinant spider silk. Operations are set to begin immediately, with expectations of producing hundreds of kilograms per month and possibly reaching multiple metric tons by Q1 2023. The contractor, already equipped with Kraig's proprietary technology, will undergo a 90-day ramp-up for initial deliveries. Kraig Labs will gain minority ownership in the production facility, ensuring oversight of financial records and operations as they aim to deliver eco-friendly spider silk to the market.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has announced the successful development of new hybrid Dragon Silk^TM silkworms aimed at enhancing large-scale production in Vietnam. These new breeds are designed to produce larger cocoons and longer silk filaments, which will significantly lower production costs and improve throughput. This initiative builds on the company's hybridization program initiated in 2018, resulting in silk cocoons that are 30-100% larger than traditional non-hybrid silkworms, thus facilitating a more consistent production platform.

Kraig Biocraft Laboratories (KBLB) has selected a high-quality garment manufacturer, in collaboration with its partner Kings Group, to produce its first apparel line using Spydasilk's^TM exclusive spider silk materials. The chosen manufacturer has over 20 years of experience and strong connections within Vietnam's textile supply chain, enabling it to deliver on the vision for the brand. Kraig Labs is simultaneously developing a product launch plan that includes marketing and distribution strategies, with expectations for further updates on production and market advancements.

Kraig Labs has successfully completed its third-party pilot production of recombinant spider silk, enabling the critical next phases of its business plan. The program exceeded expectations, leading to negotiations for a five-year production contract. Key management reviewed pilot production in Vietnam, with plans to produce metric tons of spider silk. The company aims to enhance production quality and is entering a phase of rapid production expansion in collaboration with subcontractors. Updates on production and development are expected soon.

Kraig Biocraft Laboratories (OTCQB: KBLB) announces a senior management visit to Vietnam for production expansion and market development. Key activities include meetings with government officials to secure additional lands and agreements for silk production, potentially scaling to 200 metric tons annually. The COO, Jon Rice, will also finalize launching the Spydasilk brand with joint venture partners. The company is enhancing its Vietnamese subsidiary, Prodigy Textiles, through advanced training and technology transfers to improve production capabilities.

Kraig Biocraft Laboratories (OTCQB: KBLB) has announced its first sample shipment of recombinant spider silk fibers for biomedical applications, following increased demand over the past two quarters. The company utilizes genetically enhanced silkworms to produce spider silk, combining its properties with established silk supply chains. With enhanced production in Vietnam, Kraig Labs aims to supply R&D samples to the medical community. COO Jon Rice noted rising demand and sees potential for significant growth in the biomedical space, which may require FDA approval for further applications.

Kraig Biocraft Laboratories (KBLB) has enhanced its production capabilities by introducing a new vendor quality assurance program to source high-quality mulberry for spider silk production. This initiative aims to support the increasing demand for its eco-friendly materials. The company reports that 85% of its silkworm output will be utilized for finished yarn production, primarily for its Spydasilk brand. With strengthened supplier relationships, Kraig Labs plans to expand its production footprint, ensuring sustainability and efficiency in meeting future material demands.

Kraig Biocraft Laboratories (OTCQB: KBLB) has commenced its first production run for Q2 2022 of recombinant spider silk. The company's subsidiary, Prodigy Textiles, has significantly increased testing throughput, nearly tenfold compared to Q1 2022. This achievement sets a new production capacity baseline, with plans in place to expand beyond current factory limits by Q2 2023. COO Jon Rice highlighted the success of the investments made in 2021, anticipating future updates on Prodigy and the commercialization of eco-friendly spider silk.